Search

Your search keyword '"Nefussy, B."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Nefussy, B." Remove constraint Author: "Nefussy, B."
31 results on '"Nefussy, B."'

Search Results

1. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

2. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

3. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

4. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

5. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

7. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

8. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

10. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

11. Common genetic basis of ALS patients and soccer players may contribute to disease risk.

12. Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression.

13. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.

14. The NEALS primary lateral sclerosis registry.

15. A novel mutation in TARDBP segregates with amyotrophic lateral sclerosis in a large family with early onset and fast progression.

16. Rare homozygosity in amyotrophic lateral sclerosis suggests the contribution of recessive variants to disease genetics.

17. Early post-marketing experience with edaravone in an unselected group of patients with ALS.

18. "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities.

19. High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype.

20. OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes.

21. Whole brain fiber-based comparison (FBC)-A tool for diffusion tensor imaging-based cohort studies.

22. Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.

23. Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction.

24. Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.

25. A potential tool for the diagnosis of ALS based on diffusion tensor imaging.

26. Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis.

27. Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis.

28. Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies.

29. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study.

30. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?

31. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis.

Catalog

Books, media, physical & digital resources